celastrol has been researched along with 2-(4-chlorophenyl)-1,2-benzothiazol-3-one in 1 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (2-(4-chlorophenyl)-1,2-benzothiazol-3-one) | Trials (2-(4-chlorophenyl)-1,2-benzothiazol-3-one) | Recent Studies (post-2010) (2-(4-chlorophenyl)-1,2-benzothiazol-3-one) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 8 | 0 | 3 |
| Protein | Taxonomy | celastrol (IC50) | 2-(4-chlorophenyl)-1,2-benzothiazol-3-one (IC50) |
|---|---|---|---|
| MPI protein | Homo sapiens (human) | 2.45 | |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 12.3767 | |
| hexokinase | Trypanosoma brucei brucei TREU927 | 1.1 | |
| phosphomannomutase 2 | Homo sapiens (human) | 35.6 | |
| glucose-6-phosphate 1-dehydrogenase isoform b | Homo sapiens (human) | 10.5 | |
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 34.69 | |
| Neutrophil elastase | Homo sapiens (human) | 1.1 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 0.39 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.39 | |
| Mannose-6-phosphate isomerase | Homo sapiens (human) | 1.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
1 other study(ies) available for celastrol and 2-(4-chlorophenyl)-1,2-benzothiazol-3-one
| Article | Year |
|---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |